精元康方治疗中晚期恶性肿瘤研究进展  

Research Progress of Jingyuankang Prescription on Treatment of Middle and Advanced Malignant Tumors

作　　者：王留芳 唐玉君 蒋士卿[2] 蒋立峰[3] WANG Liufang;TANG Yujun;JIANG Shiqing;JIANG Lifeng(Henan University of Chinese Medicine,Zhengzhou 450000,China;The First Affiliated Hospital of Henan University of CM,Zhengzhou 450000,China;Henan Cancer Hospital,Zhengzhou 450000,China)

机构地区：[1]河南中医药大学,河南郑州450000 [2]河南中医药大学第一附属医院,河南郑州450000 [3]河南省肿瘤医院,河南郑州450000

出　　处：《中国中医药图书情报杂志》2023年第6期234-236,F0003,共4页Chinese Journal of Library and Information Science for Traditional Chinese Medicine

基　　金：国家自然科学基金(U1704181);河南省中医药科学研究专项基金(2019ZYZD06)。

摘　　要：中医药在改善恶性肿瘤患者临床症状、提高放化疗疗效、降低毒副作用、延长生存期等方面疗效显著。本文基于温阳解毒法就精元康方治疗中晚期恶性肿瘤相关基础研究及临床研究做一综述,以期为临床治疗恶性肿瘤提供参考。TCM is effective in improving the clinical symptoms of patients with malignant tumors,improving the efficacy of radiotherapy and chemotherapy,reducing toxic and side effects,and prolonging survival time.This article reviewed the basic research and clinical research progress of Jingyuankang Prescription in the treatment of middle and advanced malignant tumors based on the method of warming yang detoxification,in order to provide reference for clinical treatment of malignant tumors.

关 键 词：温阳解毒法 精元康 中晚期恶性肿瘤 可行性 综述 

分 类 号：R273[医药卫生—中西医结合]